PreprintCited by 200Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

The DOI matches its Crossref record.

A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain

Open access

Preprint — published as 10.3390/ijms22020835 · Paper page

Abstract

A single dose of psilocybin, a psychedelic and serotonin 2A receptor (5-HT2AR) agonist, may be associated with antidepressant effects. The mechanism behind its antidepressive action is unknown but could be linked to increased synaptogenesis and down-regulation of cerebral 5-HT2AR. Here, we investigate if a single psychedelic dose of psilocybin changes synaptic vesicle protein 2A (SV2A) and 5-HT2AR density in the pig brain. Twenty-four awake pigs received either 0.08 mg/kg psilocybin or saline intravenously. Twelve pigs (n=6/intervention) were euthanized one day post-injection, while the remaining twelve pigs were euthanized seven days post-injection (n=6/intervention). We performed autoradiography on hippocampus and prefrontal cortex (PFC) sections with [3H]UCB-J (SV2A), [3H]MDL100907 (5-HT2AR antagonist) and [3H]Cimbi-36 (5-HT2AR agonist). One day post psilocybin injection, we observed 4.4% higher hippocampal SV2A density and lowered hippocampal and PFC 5-HT2AR density (-15.21% to -50.19%). These differences were statistically significant in the hippocampus for all radioligands and in PFC for [3H]Cimbi-36 only. Seven days post-intervention, there was still significantly higher SV2A density in hippocampus (+9.24%) and PFC (+6.1%) whereas there were no longer any differences in 5-HT2AR density. Our findings suggest that psilocybin’s antidepressive actions are linked to increased persistent synaptogenesis and possibly also to an acute decrease in 5-HT2AR density.

Overview

Integrity signals

Registry

Crossref · 10.20944/preprints202011.0742.v1

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A single dose of psilocybin at a presumably hallucinogenic dose (0.1 mg/kg, i.v.) reduced by up to 50% the cortical abundance of 5HT2A binding sites labelled in vitro with [3H]-MDL100907 or [3H]-Cimbi-36.

    “Recent work shows that a single dose of psilocybin (2) at a presumably hallucinogenic dose (0.1 mg/kg, i.v.) reduced by up to 50% the cortical abundance of 5HT2A binding sites labelled in vitro with [3H]-MDL100907 or [3H]-Cimbi-36 [108].”

Citations

Cited by

Sorted by citations

Metadata

Authors
Raval, N. R., Johansen, A., Donovan, L. L., Ros, N. F., Ozenne, B., Hansen, H. D., & Knudsen, G. M.
Affiliations
  • University of Copenhagen (DK)
  • Copenhagen University Hospital (DK)
  • Harvard University (US)
Corresponding author
  • Hansen, Hanne Demant
  • Knudsen, Gitte Moos
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2020-11-30
Volume
22
Issue
2
Pages
835-835
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3108222140
Cited by
200
References
0
Citations by year
2026: 31 · 2025: 38 · 2024: 40 · 2023: 41 · 2022: 33 · 2021: 17
FWCI
22.34
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • Preprints.org (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
Funders
  • European Commission (813528, HORIZON2020)
  • Lundbeckfonden (R293-2018-738, R233-2016-3416, R180-2014-3171)
  • H. Lundbeck A/S
  • Horizon 2020 Framework Programme (813528)
  • National Institute of Mental Health
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
psilocybin, 5-HT2A receptor, synaptic density, synaptogenesis, SV2A, hippocampus, prefrontal cortex, antidepressant mechanism, psychedelics, pig brain, receptor down-regulation
MeSH terms
Animals, Antidepressive Agents, Autoradiography, Brain, Female, Hallucinogens, Hippocampus, Ligands, Psilocybin, Swine, Synapses, Prefrontal Cortex, Receptor, Serotonin, 5-HT2A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review